+1,224.9%
THC vs BBIO
+148.5%
+1,076.3%
-71.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.9% | +1.8% | +2.1% | +3.6% |
| 7D | +4.1% | -0.5% | +4.6% | +4.2% |
| 30D | +3.5% | -10.1% | +13.7% | +5.0% |
| 3M | +61.7% | +12.4% | +49.3% | +59.0% |
| 6M | +11.8% | +15.9% | -4.1% | +9.1% |
| YTD | +35.4% | -0.5% | +35.9% | +34.1% |
| 1Y | +37.0% | +42.2% | -5.2% | +29.0% |
| 3Y | +260.1% | +167.8% | +92.3% | +201.7% |
| 5Y | +262.6% | +49.6% | +213.0% | +170.6% |
| All | +1,224.9% | +148.5% | +1,076.3% | +601.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling